BRIEF-Arena Pharma, EISAI announce FDA approval of BELVIQ XR extended-release tablets

* Arena pharmaceuticals inc says in connection with approval, arena will receive a $10 million milestone payment.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.